Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(23)00298-9/fulltext?dgcid=hubspot_update_feature_updatealerts_lanrhe&utm_campaign=update-lanrhe&utm_medium=email&_hsmi=293160023&_hsenc=p2ANqtz--g21-8NoIcMTXG55na7ouqQT1m7B7wedBWVv9J6Sg9YS2wbq8f4lYFzebhN7KJmu3siF5mkE7poK_uA3v7G7l1Kbu5AA&utm_content=293115722&utm_source=hs_email